ATON PORTAGE BIOTECH INC.

Nasdaq portagebiotech.com


$ 3.16 $ 0.00 (0 %)    

Monday, 24-Nov-2025 09:04:19 EST
QQQ $ 595.05 $ 0.00 (0 %)
DIA $ 463.64 $ 0.00 (0 %)
SPY $ 662.64 $ 0.00 (0 %)
TLT $ 89.91 $ 0.00 (0 %)
GLD $ 375.35 $ 0.00 (0 %)
$ 2.92
$ 2.63
$ 3.16 x 190
$ 3.16 x 344
-- - --
$ 2.62 - $ 15.82
54,966
na
6.65M
$ 1.18
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 alphaton-capital-steps-in-with-51-offer-for-forbes-media

AlphaTON to acquire 51% stake in Forbes Media Holdings, plans to leverage blockchain for verified financial journalism and data.

Core News & Articles

AlphaTON Capital (NASDAQ:ATON), a specialized digital asset technology company focused on the Telegram ecosystem, today announc...

Core News & Articles

AlphaTON Capital Corp. (NASDAQ:ATON) ("AlphaTON" or the "Company"), a specialized digital asset technology comp...

Core News & Articles

AlphaTON Capital Corp. (NASDAQ:ATON), a leading digital asset company focused on growing the Telegram ecosystem, today announce...

Core News & Articles

AlphaTON Capital Corp ("AlphaTON Capital" or the "Company") (NASDAQ:ATON) – AlphaTON Capital, a leading investm...

Core News & Articles

AlphaTON Capital Corp ("AlphaTON Capital" or the "Company") (NASDAQ:ATON), a specialized digital asset treasury...

Core News & Articles

AlphaTON Capital (NASDAQ:ATON), a leading digital asset infrastructure company focused on Telegram and the TON blockchain ecosy...

Core News & Articles

AlphaTON Capital Corp (Nasdaq: ATON) and its wholly owned oncology-focused subsidiary Tarus Therapeutics, LLC, operating as Cyn...

Core News & Articles

Telegram's more than 1 billion monthly active users represent the world's largest untapped market for AI agents that ac...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION